Wednesday, May 14, 2025
  • About Us
  • Contact Us
  • Privacy Policy
  • Login
unfoldingmatrix
  • wellness
  • spiritual
  • alternative health
  • new age
  • science
  • strange news
No Result
View All Result
Plugin Install : Cart Icon need WooCommerce plugin to be installed.
unfoldingmatrix
  • wellness
  • spiritual
  • alternative health
  • new age
  • science
  • strange news
No Result
View All Result
Plugin Install : Cart Icon need WooCommerce plugin to be installed.
unfoldingmatrix
No Result
View All Result

GSK pays $70M to increase its access to Tempus patient data library

unfoldingmatrix by unfoldingmatrix
October 19, 2022
in wellness
0 0
0



British multinational pharmaceutical and biotech company GSK announced a three-year agreement with a $70 million initial payment to expand its access to Tempus’ AI-powered data library, including its de-identified patient data. 

GSK says the collaboration will allow it to leverage the U.S.-based company’s library to accelerate drug discovery in oncology, improve its clinical trial design, identify drug targets and speed up trial enrollment. 

After three years, GSK has the option to extend the agreement for an additional two years.  

The collaboration builds on GSK and Tempus‘ existing partnership focused on clinical trial enrollment of patients with specific cancer types, allowing GSK to access Tempus’ de-identified patient data specifically. 

The companies are currently collaborating on an open-label phase II study, using a data-driven approach designed to speed up study timelines. 

“This collaboration will provide GSK with unique insights to discover better medicines and transform drug discovery. Tempus complements the work our team is already doing at the intersection of genomics and machine learning across both early discovery and clinical trials,” Tony Wood, chief scientific officer at GSK, said in a statement.

THE LARGER TREND

GSK has partnered with numerous companies in the past year to boost its clinical research functions.   

In April of this year, GSK announced a multiyear drug discovery partnership with AI-enabled pathology company PathAI to advance clinical trials and drug development in oncology and for nonalcoholic steatohepatitis (NASH). 

Earlier this year, GSK announced it extended its drug discovery partnership with consumer genetics company 23andMe until July 2023. That collaboration began in 2018 when GSK provided $300 million to the now publicly traded company.

Last year, GSK expanded its partnership with Viome Life Sciences, a maker of at-home tests for gut and immune system health. The alliance allows GSK to study the connection between the gut microbiome and some chronic diseases, like autoimmune disorders.



Source link

ShareTweetShare
unfoldingmatrix

unfoldingmatrix

Next Post
GE Healthcare, AMC Health announce remote patient monitoring partnership

GE Healthcare, AMC Health announce remote patient monitoring partnership

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

US Hurricane Death Toll Is 300 Times Official Counts, Study Estimates : ScienceAlert
science

US Hurricane Death Toll Is 300 Times Official Counts, Study Estimates : ScienceAlert

by unfoldingmatrix
October 4, 2024
Location of Impulse Control Found in Brain, May Help Parkinson’s Patients : ScienceAlert
science

Location of Impulse Control Found in Brain, May Help Parkinson’s Patients : ScienceAlert

by unfoldingmatrix
October 4, 2024
Expect Stunning Auroras : ScienceAlert
science

Expect Stunning Auroras : ScienceAlert

by unfoldingmatrix
October 4, 2024
Smoking Ban For Gen Z Could Save 1.2 Million Lives, Study Finds : ScienceAlert
science

Smoking Ban For Gen Z Could Save 1.2 Million Lives, Study Finds : ScienceAlert

by unfoldingmatrix
October 4, 2024
Dietary Supplement Found to Reduce Aggression by Up to 28% : ScienceAlert
science

One Dietary Supplement Found to Reduce Aggression by Up to 28% : ScienceAlert

by unfoldingmatrix
October 4, 2024
CERN Confirms Ultra-Rare Particle Transformation, Hints at New Physics : ScienceAlert
science

CERN Confirms Ultra-Rare Particle Transformation, Hints at New Physics : ScienceAlert

by unfoldingmatrix
October 3, 2024
The Link Between Food and Cervical Wellness in Women |
alternative health

The Link Between Food and Cervical Wellness in Women |

by unfoldingmatrix
October 3, 2024
Candy is the Official Treat of Halloween Season |
alternative health

Candy is the Official Treat of Halloween Season |

by unfoldingmatrix
October 3, 2024

Categories

  • alternative health
  • new age
  • science
  • spiritual
  • strange news
  • wellness

Important

  • About Us
  • Contact Us
  • Privacy Policy

Recent News

US Hurricane Death Toll Is 300 Times Official Counts, Study Estimates : ScienceAlert

US Hurricane Death Toll Is 300 Times Official Counts, Study Estimates : ScienceAlert

October 4, 2024

© 2022 unfoldingmatrix.com

No Result
View All Result
  • wellness
  • spiritual
  • alternative health
  • new age
  • science
  • strange news

© 2022 unfoldingmatrix.com

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In